Term Name: motixafortide acetate
Synonyms: (3S,6S,9S,12R,17R,20S,23S,26S,29R,34aS)-26,29-bis(4-aminobutyl)-N-[(2S)-1-amino-5-carbamimidamido-1-oxopentan-2-yl]-17-{[(2S)-2-{[(2S)-5-carbamimidamido-2-{[(2S)-5-carbamimidamido-2-(4-fluorobenzamido)pentanoyl]amino}pentanoyl]amino}-3-(naphthalen-2-yl)pr, Aphexda, BL-8040 acetate, N-(4-fluoro-benzoyl)-L-arginyl-L-arginyl-[L-3- (naphthyl)alanyl]-L-cysteinyl-L-tyrosyl(5)-L-citrullinyl-L-lysyl-D-lysyl-L-prolyl-L-tyrosyl(10)- L-arginyl-L-citrullinyl-L-cysteinyl-L-arginineamide, cyclic (4-13)-disulfide, acetate salt, TF-14016 acetate
Definition: A acetate salt obtained by combining motixafortide with six molar equivalents of acetic acid. It is a drug that was approved for use in combination with filgrastim to mobilize hematopoietic stem cells for collection and subsequent autologous transplantation in patients with multiple myeloma.
Ontology: ChEBI [CHEBI:229224]  ( EBI )

Relationships
is a type of: acetate salt
has_part: motixafortide
has_role: antineoplastic agent apoptosis inducer C-X-C chemokine receptor type 4 antagonist